Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3789289 | 0.90 | BRD9 (0.45) | BRD9HSP90AA1HSP90AB1LMNAPOLB | |
| SCHEMBL3788603 | 0.88 | HSP90AA1 (0.46) | BRD9HSP90AA1HSP90AB1LMNAPOLB | |
| SCHEMBL3791007 | 0.88 | BRD9 (0.43) | BRD9HSP90AA1HSP90AB1LMNAPOLB | |
| SCHEMBL3784001 | 0.88 | BRD9 (0.43) | BRD9HSP90AA1HSP90AB1LMNAPOLB | |
| SCHEMBL211033 | 0.87 | HDAC1 (0.52) | BRD9LMNAPOLBRXFP1HDAC1 | |
| SCHEMBL29353000 | 0.87 | HDAC1 (0.52) | BRD9LMNAPOLBRXFP1HDAC1 | |
| SCHEMBL25066473 | 0.84 | HDAC3 (0.45) | LMNAHDAC1ALDH1A1L3MBTL1HDAC3 | |
| SCHEMBL3787700 | 0.84 | ATR (0.39) | BRD9HSP90AA1HSP90AB1LMNAPOLB | |
| SCHEMBL4414634 | 0.83 | LMNA (0.48) | BRD9HSP90AA1HSP90AB1LMNAPOLB | |
| SCHEMBL1172444 | 0.83 | RXFP1 (0.44) | BRD9HSP90AA1HSP90AB1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2174928-B1 | TRANSITION METAL COMPLEX COMPOUND, OLEFIN OLIGOMERIZATION CATALYST CONTAINING THE COMPOUND, AND METHOD FOR PRODUCING OLEFIN OLIGOMER PERFORMED IN THE PRESENCE OF THE CATALYST | MITSUI CHEMICALS INC (JP) | 2015-03-11 | — | — | EP | disclosed |
| US-8258361-B2 | Transition metal complex compounds, olefin oligomerization catalysts including the compounds, and processes for producing olefin oligomers using the catalysts | MITSUI CHEMICALS, INC. (JP) | 2012-09-04 | — | — | US | disclosed |
| US-8258361-B2 | Transition metal complex compounds, olefin oligomerization catalysts including the compounds, and processes for producing olefin oligomers using the catalysts | MITSUI CHEMICALS, INC. (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20110082325-A1 | TRANSITION METAL COMPLEX COMPOUNDS, OLEFIN OLIGOMERIZATION CATALYSTS INCLUDING THE COMPOUNDS, AND PROCESSES FOR PRODUCING OLEFIN OLIGOMERS USING THE CATALYSTS | MITSUI CHEMICALS, INC. | 2011-04-07 | — | — | US | disclosed |
| US-20110082325-A1 | TRANSITION METAL COMPLEX COMPOUNDS, OLEFIN OLIGOMERIZATION CATALYSTS INCLUDING THE COMPOUNDS, AND PROCESSES FOR PRODUCING OLEFIN OLIGOMERS USING THE CATALYSTS | MITSUI CHEMICALS, INC. | 2011-04-07 | — | — | US | disclosed |
| EP-2174928-A1 | TRANSITION METAL COMPLEX COMPOUND, OLEFIN POLYMERIZATION CATALYST CONTAINING THE COMPOUND, AND METHOD FOR PRODUCING OLEFIN POLYMER PERFORMED IN THE PRESENCE OF THE CATALYST | Mitsui Chemicals, Inc. (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082325-A1 | TRANSITION METAL COMPLEX COMPOUNDS, OLEFIN OLIGOMERIZATION CATALYSTS INCLUDING THE COMPOUNDS, AND PROCESSES FOR PRODUCING OLEFIN OLIGOMERS USING THE CATALYSTS | OSTC, COG4, COG7 | BRD9 3554/4885HSP90AA1 3853/4885HSP90AB1 3782/4885 |
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | BRD9 247/4885HSP90AA1 4759/4885HSP90AB1 4609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.